Cargando…

Author Correction: Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations

Detalles Bibliográficos
Autores principales:	Kulemann, Birte, Rösch, Stephanie, Seifert, Sindy, Timme, Sylvia, Bronsert, Peter, Seifert, Gabriel, Martini, Verena, Kuvendjiska, Jasmina, Glatz, Torben, Hussung, Saskia, Fritsch, Ralph, Becker, Heiko, Pitman, Martha B., Hoeppner, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666001/ https://www.ncbi.nlm.nih.gov/pubmed/29079791 http://dx.doi.org/10.1038/s41598-017-14870-3

Ejemplares similares

Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
por: Kulemann, Birte, et al.
Publicado: (2017)

Non-Metastatic Esophageal Adenocarcinoma: Circulating Tumor Cells in the Course of Multimodal Tumor Treatment
por: Kuvendjiska, Jasmina, et al.
Publicado: (2019)

Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials
por: Glatz, Torben, et al.
Publicado: (2020)

Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives
por: Martini, Verena, et al.
Publicado: (2019)

Hybrid Minimally Invasive Esophagectomy–Surgical Technique and Results
por: Kuvendjiska, Jasmina, et al.
Publicado: (2019)

Cancer-associated Macrophage-like Cells in Patients with Non-metastatic Adenocarcinoma of the Esophagus - Cytomorphological Heterogeneity
por: Braun, Clara, et al.
Publicado: (2023)

Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasm of the Pancreas
por: Kuvendjiska, Jasmina, et al.
Publicado: (2023)

Pathological complete response in multimodal treatment of esophageal cancer: a retrospective cohort study
por: Hipp, Julian, et al.
Publicado: (2022)

The degree of local inflammatory response after colonic resection depends on the surgical approach: an observational study in 61 patients
por: Glatz, Torben, et al.
Publicado: (2015)

The effect of pasireotide on intestinal anastomotic healing with and without whole-body irradiation in a rat model
por: Seifert, Gabriel J., et al.
Publicado: (2018)

Oncological recurrence following pathological complete response after neoadjuvant treatment in patients with esophageal cancer — a retrospective cohort study
por: Hipp, Julian, et al.
Publicado: (2023)

Postoperative fluid overload is a risk factor for adverse surgical outcome in patients undergoing esophagectomy for esophageal cancer: a retrospective study in 335 patients
por: Glatz, Torben, et al.
Publicado: (2017)

Complications after pancreaticoduodenectomy are associated with higher amounts of intra- and postoperative fluid therapy: A single center retrospective cohort study
por: Kulemann, Birte, et al.
Publicado: (2017)

The Prognostic Impact of the Carcinoembryonic Antigen in Ampullary Cancer - A Retrospective Single Center Study
por: Fuellgraf, Hannah, et al.
Publicado: (2017)

Metastasis and Tumor Cell Migration of Solid Tumors
por: Hoeppner, Jens, et al.
Publicado: (2021)

Mesopancreatic Stromal Clearance Defines Curative Resection of Pancreatic Head Cancer and Can Be Predicted Preoperatively by Radiologic Parameters: A Retrospective Study
por: Wellner, Ulrich F., et al.
Publicado: (2016)

Prognostic impact of tumor budding and EMT in periampullary adenocarcinoma: a quantitative approach
por: Kocsmár, Éva, et al.
Publicado: (2020)

ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma
por: Oria, Victor O., et al.
Publicado: (2019)

Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer
por: Hussung, Saskia, et al.
Publicado: (2021)

Proximal gastrectomy and double-tract reconstruction vs total gastrectomy in gastric and gastro-esophageal junction cancer patients — a systematic review and meta-analysis protocol (PROSPERO registration number: CRD42021291500)
por: Hipp, Julian, et al.
Publicado: (2023)

Postoperative Hiatal Hernia after Ivor Lewis Esophagectomy—A Growing Problem in the Age of Minimally Invasive Surgery
por: Kuvendjiska, Jasmina, et al.
Publicado: (2023)

Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma
por: Klett, Hagen, et al.
Publicado: (2018)

Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma
por: Rittmann, Marie-Claire, et al.
Publicado: (2021)

ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)
por: Hoeppner, Jens, et al.
Publicado: (2016)

Conditional Gene Targeting Reveals Cell Type-Specific Roles of the Lysosomal Protease Cathepsin L in Mammary Tumor Progression
por: Parigiani, María Alejandra, et al.
Publicado: (2020)

Pregnancy Specific β-1 Glycoprotein 1 is Expressed in Pancreatic Ductal Adenocarcinoma and its Subcellular Localization Correlates with Overall Survival
por: Shahinian, Jasmin H., et al.
Publicado: (2016)

Targeting the Tumor Microenvironment: An Unexplored Strategy for Mutant KRAS Tumors
por: Dias Carvalho, Patrícia, et al.
Publicado: (2019)

Perioperative FLOT chemotherapy plus surgery for oligometastatic esophagogastric adenocarcinoma: surgical outcome and overall survival
por: Runkel, Mira, et al.
Publicado: (2021)

Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management
por: Wehrle, Julius, et al.
Publicado: (2020)

Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
por: Indini, Alice, et al.
Publicado: (2021)

KRAS mutant colorectal tumors: Past and present
por: Brand, Toni M., et al.
Publicado: (2012)

Twists and turns in Kras-driven tumor initiation
por: Maru, Yoshiaki, et al.
Publicado: (2021)

Transformation of immunosuppressive mtKRAS tumors into immunostimulatory tumors by Nerofe and Doxorubicin
por: Ohana, Joel, et al.
Publicado: (2023)

Metabolic Profiling of Early and Late Recurrent Pancreatic Ductal Adenocarcinoma Using Patient-Derived Organoid Cultures
por: Braun, Lukas M., et al.
Publicado: (2020)

Prognostic Implications of PET-Derived Tumor Volume and Uptake in Patients with Neuroendocrine Tumors
por: Weber, Manuel, et al.
Publicado: (2023)

Epidural analgesia and avoidance of blood transfusion are associated with reduced mortality in patients with postoperative pulmonary complications following thoracotomic esophagectomy: a retrospective cohort study of 335 patients
por: Kaufmann, Kai B., et al.
Publicado: (2019)

Comparison of Mutated KRAS and Methylated HOXA9 Tumor-Specific DNA in Advanced Lung Adenocarcinoma
por: Wen, Sara W. C., et al.
Publicado: (2020)

Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab
por: Dunn, Emily F., et al.
Publicado: (2010)

Oncogenic KRAS promotes malignant brain tumors in zebrafish
por: Ju, Bensheng, et al.
Publicado: (2015)

Zebrafish model of KRAS-initiated pancreatic endocrine tumor
por: Oh, Sekyung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0p5alvf3ke53o2fqcl59hdiatm